Judge Steps Aside from Black-Market HIV Drug Case After Surprise Stock Buy Sparks Conflict Concerns
A high-stakes case over counterfeit HIV medications has taken an unexpected turn: the federal judge overseeing it has removed herself after learning her own brokerage account briefly held shares of Gilead Sciences, the pharmaceuticalâŚ
